Results 71 to 80 of about 2,171 (174)

Generation of Novel Natural Products by Disrupting Azaphilone Synthesis in <i>Penicillum sclerotiorum</i> E23Y-1A. [PDF]

Mar Drugs
Chang W, Yang Y, Duan R, Qin H, Chen S, Zeng Y.   +5 more
europepmc   +1 more source

Breeding of a higher producer enables identification of a negative transcription factor controlling the biosynthesis of xiamenmycin in <i>Streptomyces xiamenensis</i>. [PDF]

Synth Syst Biotechnol
He WY, Li JX, Bu XL, Cheng RT, Wang L, Tao SC, Xu J, Xu MJ.   +7 more
europepmc   +1 more source

Synthesis of 2-aminopropyl benzopyran derivatives as potential agents against triple-negative breast cancer. [PDF]

RSC Med Chem, 2023
García A, Torres-Ruiz S, Vila L, Villarroel-Vicente C, Bernabeu Á, Eroles P, Cabedo N, Cortes D.   +7 more
europepmc   +1 more source

Fulvic acid protects hepatic tissue from amoxicillin/clavulanate-induced hepatotoxicity. [PDF]

J Vet Sci
Durgun HM, Yildizhan E.
europepmc   +1 more source

Histopathological features and eight-week split-tablet sofosbuvir/velpatasvir treatment in young children with acute hepatitis C: a case-series study. [PDF]

BMC Infect Dis
Pan YJ, Chen RY, Ai YQ, Zeng QL.
europepmc   +1 more source

Benzochromanone and Benzochromene Natural Products: Synthetic Strategies and Total Syntheses. [PDF]

Chem Rec
Kumamoto T.
europepmc   +1 more source

Two taxonomically similar plant species are projected to become the key alternative wild resources to Ardisia crenata Sims. [PDF]

BMC Plant Biol
Wang X, Pan L, Liu S, Li S, Zhou Y, Ouyang Q, Ma Y, Wang Q, Huang B, Wu F.   +9 more
europepmc   +1 more source

Photochemical Deracemization of Chromanes and its Application to the Synthesis of Enantiopure Bioactive Compounds. [PDF]

Angew Chem Int Ed Engl
Ghosh B, Iglhaut M, Babushkina D, Pauls M, Bannwarth C, Bach T.   +5 more
europepmc   +1 more source

Simplified monitoring of sofosbuvir/velpatasvir in Japanese patients with chronic hepatitis C based on a retrospective analysis of a prospective multicenter cohort. [PDF]

Sci Rep
Suda G, Baba M, Yamamoto Y, Yoshida S, Muranaka T, Meguro T, Terashita K, Ito J, Kobayashi T, Izumi T, Takagi T, Hosoda S, Yamada R, Fu Q, Yang Z, Yokoyama D, Tanaka T, Meno A, Yasuura N, Kitagataya T, Ohara M, Kawagishi N, Nakai M, Sho T, Ogawa K, Sakamoto N.   +25 more
europepmc   +1 more source

Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16-24 weeks. [PDF]

J Virol
Fedorchenko SV, Klimenko Z, Martynovich T, Solianyk I, Suprunenko T.   +4 more
europepmc   +1 more source